Literature DB >> 33864055

Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells.

Julia Vallverdú1, Raquel A Martínez García de la Torre1, Catherine M Verfaillie2, Leo A van Grunsven3, Pau Sancho-Bru4,5, Inge Mannaerts6, Stefaan Verhulst6, Ayla Smout6, Mar Coll1,7, Silvia Ariño1, Teresa Rubio-Tomás1, Beatriz Aguilar-Bravo1, Celia Martínez-Sánchez1, Delia Blaya1.   

Abstract

Hepatic stellate cells (HSCs) are nonparenchymal liver cells responsible for extracellular matrix homeostasis and are the main cells involved in the development of liver fibrosis following injury. The lack of reliable sources of HSCs has hence limited the development of complex in vitro systems to model liver diseases and toxicity. Here we describe a protocol to differentiate human induced pluripotent stem cells (iPSCs) into hepatic stellate cells (iPSC-HSCs). The protocol is based on the addition of several growth factors important for liver development sequentially over 12 d. iPSC-HSCs present phenotypic and functional characteristics of primary HSCs and can be expanded or frozen and used to perform high-throughput in vitro studies. We also describe how to coculture iPSC-HSCs with hepatocytes, which self-assemble into three-dimensional (3D) hepatic spheroids. This protocol enables the generation of HSC-like cells for in vitro modeling and drug screening studies.

Entities:  

Year:  2021        PMID: 33864055     DOI: 10.1038/s41596-021-00509-1

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  3 in total

1.  Glaucocalyxin A alleviates lipopolysaccharide-induced inflammation and apoptosis in pulmonary microvascular endothelial cells and permeability injury by inhibiting STAT3 signaling.

Authors:  Jianwei Cao; Meiling Liu; Shufang Feng; Yingying Li; Kaijun Zheng
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

Review 2.  Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery.

Authors:  Tine Tricot; Catherine M Verfaillie; Manoj Kumar
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

3.  Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays.

Authors:  Christian Moya Gamboa; Yujue Wang; Huiting Xu; Katarzyna Kalemba; Fredric E Wondisford; Hatem E Sabaawy
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.